Publications by authors named "V Peral"

Claim this Profile
R
Rationale and design of REAC-TAVI 2: Single antiplatelet treatment with ticagrelor vs aspirin after transcatheter aortic valve implantation.
Kimberley I Hemelrijk, Victor A Jimenez-Diaz, Jean Paul Vilchez, Juan F Oteo, Ivan Gomez-Blazquez, Vicente Peral

Am Heart J· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trial.
Elfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, Martin Hudec, Matjaz Bunc, Vicente Peral

Int J Cardiol Heart Vasc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial.
Patrick W Serruys, Akihiro Tobe, Niels van Royen, Ignacio J Amat-Santos, Martin Hudec, Vicente Peral

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left atrial appendage closure in patients with prior intracranial bleeding, safety, efficacy, and timing.
D Gonzalez-Calle, L Nombela-Franco, H Gutierrez-Garcia, V Peral, J Mesnier

Neurologia (Engl Ed)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK Trial.
Osama Soliman, Elfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, Martin Hudec, Vicente Peral

Eur Heart J Cardiovasc Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis